GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » CHC Healthcare Group (TPE:4164) » Definitions » EBITDA Margin %

CHC Healthcare Group (TPE:4164) EBITDA Margin % : 28.67% (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is CHC Healthcare Group EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. CHC Healthcare Group's EBITDA for the three months ended in Mar. 2024 was NT$189 Mil. CHC Healthcare Group's Revenue for the three months ended in Mar. 2024 was NT$658 Mil. Therefore, CHC Healthcare Group's EBITDA margin for the quarter that ended in Mar. 2024 was 28.67%.


CHC Healthcare Group EBITDA Margin % Historical Data

The historical data trend for CHC Healthcare Group's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CHC Healthcare Group EBITDA Margin % Chart

CHC Healthcare Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.77 38.48 41.57 35.45 32.06

CHC Healthcare Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.46 34.17 31.59 29.68 28.67

Competitive Comparison of CHC Healthcare Group's EBITDA Margin %

For the Medical Distribution subindustry, CHC Healthcare Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CHC Healthcare Group's EBITDA Margin % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, CHC Healthcare Group's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where CHC Healthcare Group's EBITDA Margin % falls into.



CHC Healthcare Group EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

CHC Healthcare Group's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=1242.894/3877.137
=32.06 %

CHC Healthcare Group's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=188.543/657.618
=28.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CHC Healthcare Group  (TPE:4164) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


CHC Healthcare Group EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of CHC Healthcare Group's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


CHC Healthcare Group (TPE:4164) Business Description

Traded in Other Exchanges
N/A
Address
No. 88, Xing’ai Road, Neihu District, Taipei, TWN, 114067
CHC Healthcare Group is a Taiwan based company engaged in the trading of pharmaceutical products and the sale, leasing, installation, and repair of medical instruments. It is engaged in the distribution of radiotherapy equipment, including equipment that is used in the treatment of radiation oncology, ophthalmology, dentistry, and neuroscience. It also provides medical equipment consulting for hospitals and clinics. It earns revenues from the sale of drugs, sale of medical instruments, and repairs maintenance and other services.

CHC Healthcare Group (TPE:4164) Headlines

No Headlines